Pfizer and Allergan deal off

Pfizer and Allergan’s merger has been scuppered by new US legislation, news agency Reuters is reporting. Pfizer has decided to terminate the agreement to acquire Allergan, a $160 billion agreement which would have seen the US pharmaceutical manufacturer move to Ireland, where Allergan is registered, and thus reduce its tax obligation. The decision came after